Transarterial- chemoembolization remains an effective therapy for intermediate-stage hepatocellular carcinoma with preserved liver function

Clicks: 242
ID: 118053
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #4 of 4 articles by views in hepatology research : the official journal of the japan society of hepatology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Superselective TACE can achieve high tumor response rates with prolonged overall survival for patients with intermediate-stage HCC with preserved liver function. Age, serum α-fetoprotein level, tumor number ≥ 11, and heterogeneous enhancement on dynamic computed tomography indicated significantly po …
Reference Key
n2020hepatologytransarterial- Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Saito N;Tanaka T;Nishiohuku H;Sato T;Masada T;Matsumoto T;Anai H;Sakaguchi H;Sueyoshi S;Marugami N;Kichikawa K;;
Journal hepatology research : the official journal of the japan society of hepatology
Year 2020
DOI
DOI not found
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.